Filing search / Petros Pharmaceuticals, Inc. / "Research and Development"

Search information

Petros Pharmaceuticals, Inc.

Companies

"Research and Development"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

45 results

Newest first Best match first

424B4

PTPI Petros Pharmaceuticals, Inc.

19 Feb 25

Prospectus supplement with pricing info

5:22pm

to raise sufficient capital to fund our operations, we may need to delay, reduce or eliminate certain research and development programs or other … business strategy and may require us to delay, reduce or eliminate certain research and development programs or other operations, sell some or all of our

S-1/A

PTPI Petros Pharmaceuticals, Inc.

IPO registration (amended)

or eliminate certain research and development programs or other operations, sell some or all of our assets or merge with another entity. Petros has incurred … , government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid

14 Feb 25

11:28am

S-1/A

PTPI Petros Pharmaceuticals, Inc.

IPO registration (amended)

so. If we are unable to raise sufficient capital to fund our operations, we may need to delay, reduce or eliminate certain research and development … to pursue our business strategy and may require us to delay, reduce or eliminate certain research and development programs or other operations, sell

13 Feb 25

9:42am

S-1/A

PTPI Petros Pharmaceuticals, Inc.

IPO registration (amended)

, we may need to delay, reduce or eliminate certain research and development programs or other operations, sell some or all of our assets or merge … to delay, reduce or eliminate certain research and development programs or other operations, sell some or all of our assets or merge with another

10 Feb 25

5:01pm

S-1

PTPI Petros Pharmaceuticals, Inc.

IPO registration

to delay, reduce or eliminate certain research and development programs or other operations, sell some or all of our assets or merge with another entity … certain research and development programs or other operations, sell some or all of our assets or merge with another entity. Table of Contents Any

24 Jan 25

5:02pm

10-Q

5p08rgqkylpqz

Quarterly report

13 Nov 24

5:11pm

10-Q

x7m3qmwkqs

Quarterly report

14 Aug 24

4:06pm

10-Q

9dk3ho

Quarterly report

15 May 24

5:00pm

S-3

2yy1qt2lhm04l24qs

Shelf registration

3 May 24

5:01pm

10-K

e6d85

Annual report

1 Apr 24

4:31pm

10-Q

14higogx8p78cao

Quarterly report

15 Nov 23

5:11pm

DEF 14A

mrw3cq7jxrkt

Definitive proxy

25 Aug 23

5:08pm

PRE 14A

50k8d0etj44em k7de3

Preliminary proxy

15 Aug 23

5:01pm

10-Q

75zkhssa

Quarterly report

14 Aug 23

5:03pm

10-Q

v0jn20940jrpiqntr5r

Quarterly report

15 May 23

5:25pm

10-K

hfjo9

Annual report

31 Mar 23

5:00pm

Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update

8:30am

10-Q/A

qzwmlf5 7hb05

Quarterly report (amended)

15 Nov 22

12:00am

10-Q

irk4iweby btvdle9y

Quarterly report

14 Nov 22

5:28pm

Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022

9:16am

Filing search / Petros Pharmaceuticals, Inc. / "Research and Development"

45 results

Top filers

Top filing types

Recent filing years